Viewing Study NCT01466504

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-02-28 @ 10:35 PM
Study NCT ID: NCT01466504
Status: TERMINATED
Last Update Posted: 2013-04-15
First Post: 2011-10-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
Sponsor: Dartmouth-Hitchcock Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
None Hepatocellular Carcinoma View
None Colorectal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None P63 View
None Sorafenib View
None Regorafenib View
None rash View
None skin toxicity View
None RCC View
None HCC View
None colorectal carcinoma View